A Short Synthetic Peptide Mimetic of Apolipoprotein A1 Mediates Cholesterol and Globotriaosylceramide Efflux from Fabry Fibroblasts
Identifieur interne : 002236 ( Main/Exploration ); précédent : 002235; suivant : 002237A Short Synthetic Peptide Mimetic of Apolipoprotein A1 Mediates Cholesterol and Globotriaosylceramide Efflux from Fabry Fibroblasts
Auteurs : Ulrike Schueler [États-Unis] ; Christine Kaneski [États-Unis] ; Alan Remaley [États-Unis] ; Stephen Demosky [États-Unis] ; Nancy Dwyer [États-Unis] ; Joan Blanchette-Mackie [États-Unis] ; John Hanover [États-Unis] ; Roscoe Brady [États-Unis]Source :
- JIMD Reports [ 2192-8304 ] ; 2015.
Abstract
Fabry disease is an X-linked sphingolipid storage disorder caused by a deficiency of the lysosomal enzyme α-galactosidase A (AGA, EC 3.2.1.22) resulting in the intracellular accumulation of globotriaosylceramide (Gb3). We found that Gb3 storage also correlates with accumulation of endosomal–lysosomal cholesterol in Fabry fibroblasts. This cholesterol accumulation may contribute to the phenotypic pathology of Fabry disease by slowing endosomal–lysosomal trafficking. We found that LDL receptor expression is not downregulated in Fabry fibroblasts resulting in accumulation of both cholesterol and Gb3. 5A-Palmitoyl oleoyl-phosphatidylcholine (5AP) is a phospholipid complex containing a short synthetic peptide that mimics apolipoprotein A1, the main protein component of high-density lipoprotein (HDL) that mediates the efflux of cholesterol from cells via the ATP-binding cassette transporter. We used 5AP and HDL to remove cholesterol from Fabry fibroblasts to examine the fate of accumulated cellular Gb3. Using immunostaining techniques, we found that 5AP is highly effective for depleting cholesterol and Gb3 in these cells. 5AP restores the ApoA-1-mediated cholesterol efflux leading to mobilization of cholesterol and reduction of Gb3 in Fabry fibroblasts.
Url:
DOI: 10.1007/8904_2015_507
PubMed: 26683465
PubMed Central: 5059196
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000B77
- to stream Pmc, to step Curation: 000B76
- to stream Pmc, to step Checkpoint: 001576
- to stream Ncbi, to step Merge: 007C44
- to stream Ncbi, to step Curation: 007C44
- to stream Ncbi, to step Checkpoint: 007C44
- to stream Main, to step Merge: 002239
- to stream Main, to step Curation: 002236
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A Short Synthetic Peptide Mimetic of Apolipoprotein A1 Mediates Cholesterol and Globotriaosylceramide Efflux from Fabry Fibroblasts</title>
<author><name sortKey="Schueler, Ulrike" sort="Schueler, Ulrike" uniqKey="Schueler U" first="Ulrike" last="Schueler">Ulrike Schueler</name>
<affiliation wicri:level="2"><nlm:aff id="Aff13">NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda, MD 20892-0851 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Kaneski, Christine" sort="Kaneski, Christine" uniqKey="Kaneski C" first="Christine" last="Kaneski">Christine Kaneski</name>
<affiliation wicri:level="2"><nlm:aff id="Aff14">NINDS National Institutes of Health, Bethesda, MD 20892-0851 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NINDS National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Remaley, Alan" sort="Remaley, Alan" uniqKey="Remaley A" first="Alan" last="Remaley">Alan Remaley</name>
<affiliation wicri:level="2"><nlm:aff id="Aff15">NHLBI Lipoprotein Metabolism Section, National Institutes of Health, Bethesda, MD USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NHLBI Lipoprotein Metabolism Section, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Demosky, Stephen" sort="Demosky, Stephen" uniqKey="Demosky S" first="Stephen" last="Demosky">Stephen Demosky</name>
<affiliation wicri:level="2"><nlm:aff id="Aff15">NHLBI Lipoprotein Metabolism Section, National Institutes of Health, Bethesda, MD USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NHLBI Lipoprotein Metabolism Section, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Dwyer, Nancy" sort="Dwyer, Nancy" uniqKey="Dwyer N" first="Nancy" last="Dwyer">Nancy Dwyer</name>
<affiliation wicri:level="2"><nlm:aff id="Aff13">NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda, MD 20892-0851 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Blanchette Mackie, Joan" sort="Blanchette Mackie, Joan" uniqKey="Blanchette Mackie J" first="Joan" last="Blanchette-Mackie">Joan Blanchette-Mackie</name>
<affiliation wicri:level="2"><nlm:aff id="Aff13">NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda, MD 20892-0851 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Hanover, John" sort="Hanover, John" uniqKey="Hanover J" first="John" last="Hanover">John Hanover</name>
<affiliation wicri:level="2"><nlm:aff id="Aff13">NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda, MD 20892-0851 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Brady, Roscoe" sort="Brady, Roscoe" uniqKey="Brady R" first="Roscoe" last="Brady">Roscoe Brady</name>
<affiliation wicri:level="2"><nlm:aff id="Aff14">NINDS National Institutes of Health, Bethesda, MD 20892-0851 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NINDS National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">26683465</idno>
<idno type="pmc">5059196</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059196</idno>
<idno type="RBID">PMC:5059196</idno>
<idno type="doi">10.1007/8904_2015_507</idno>
<date when="2015">2015</date>
<idno type="wicri:Area/Pmc/Corpus">000B77</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000B77</idno>
<idno type="wicri:Area/Pmc/Curation">000B76</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000B76</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001576</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001576</idno>
<idno type="wicri:Area/Ncbi/Merge">007C44</idno>
<idno type="wicri:Area/Ncbi/Curation">007C44</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">007C44</idno>
<idno type="wicri:doubleKey">2192-8304:2015:Schueler U:a:short:synthetic</idno>
<idno type="wicri:Area/Main/Merge">002239</idno>
<idno type="wicri:Area/Main/Curation">002236</idno>
<idno type="wicri:Area/Main/Exploration">002236</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">A Short Synthetic Peptide Mimetic of Apolipoprotein A1 Mediates Cholesterol and Globotriaosylceramide Efflux from Fabry Fibroblasts</title>
<author><name sortKey="Schueler, Ulrike" sort="Schueler, Ulrike" uniqKey="Schueler U" first="Ulrike" last="Schueler">Ulrike Schueler</name>
<affiliation wicri:level="2"><nlm:aff id="Aff13">NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda, MD 20892-0851 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Kaneski, Christine" sort="Kaneski, Christine" uniqKey="Kaneski C" first="Christine" last="Kaneski">Christine Kaneski</name>
<affiliation wicri:level="2"><nlm:aff id="Aff14">NINDS National Institutes of Health, Bethesda, MD 20892-0851 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NINDS National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Remaley, Alan" sort="Remaley, Alan" uniqKey="Remaley A" first="Alan" last="Remaley">Alan Remaley</name>
<affiliation wicri:level="2"><nlm:aff id="Aff15">NHLBI Lipoprotein Metabolism Section, National Institutes of Health, Bethesda, MD USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NHLBI Lipoprotein Metabolism Section, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Demosky, Stephen" sort="Demosky, Stephen" uniqKey="Demosky S" first="Stephen" last="Demosky">Stephen Demosky</name>
<affiliation wicri:level="2"><nlm:aff id="Aff15">NHLBI Lipoprotein Metabolism Section, National Institutes of Health, Bethesda, MD USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NHLBI Lipoprotein Metabolism Section, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Dwyer, Nancy" sort="Dwyer, Nancy" uniqKey="Dwyer N" first="Nancy" last="Dwyer">Nancy Dwyer</name>
<affiliation wicri:level="2"><nlm:aff id="Aff13">NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda, MD 20892-0851 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Blanchette Mackie, Joan" sort="Blanchette Mackie, Joan" uniqKey="Blanchette Mackie J" first="Joan" last="Blanchette-Mackie">Joan Blanchette-Mackie</name>
<affiliation wicri:level="2"><nlm:aff id="Aff13">NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda, MD 20892-0851 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Hanover, John" sort="Hanover, John" uniqKey="Hanover J" first="John" last="Hanover">John Hanover</name>
<affiliation wicri:level="2"><nlm:aff id="Aff13">NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda, MD 20892-0851 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NIDDK, LCBB, National Institutes of Health, Building 8, Room 420, 8 Center Drive, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Brady, Roscoe" sort="Brady, Roscoe" uniqKey="Brady R" first="Roscoe" last="Brady">Roscoe Brady</name>
<affiliation wicri:level="2"><nlm:aff id="Aff14">NINDS National Institutes of Health, Bethesda, MD 20892-0851 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>NINDS National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">JIMD Reports</title>
<idno type="ISSN">2192-8304</idno>
<idno type="eISSN">2192-8312</idno>
<imprint><date when="2015">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Fabry disease is an X-linked sphingolipid storage disorder caused by a deficiency of the lysosomal enzyme α-galactosidase A (AGA, EC 3.2.1.22) resulting in the intracellular accumulation of globotriaosylceramide (Gb3). We found that Gb3 storage also correlates with accumulation of endosomal–lysosomal cholesterol in Fabry fibroblasts. This cholesterol accumulation may contribute to the phenotypic pathology of Fabry disease by slowing endosomal–lysosomal trafficking. We found that LDL receptor expression is not downregulated in Fabry fibroblasts resulting in accumulation of both cholesterol and Gb3. 5A-Palmitoyl oleoyl-phosphatidylcholine (5AP) is a phospholipid complex containing a short synthetic peptide that mimics apolipoprotein A1, the main protein component of high-density lipoprotein (HDL) that mediates the efflux of cholesterol from cells via the ATP-binding cassette transporter. We used 5AP and HDL to remove cholesterol from Fabry fibroblasts to examine the fate of accumulated cellular Gb3. Using immunostaining techniques, we found that 5AP is highly effective for depleting cholesterol and Gb3 in these cells. 5AP restores the ApoA-1-mediated cholesterol efflux leading to mobilization of cholesterol and reduction of Gb3 in Fabry fibroblasts.</p>
</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Maryland</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Maryland"><name sortKey="Schueler, Ulrike" sort="Schueler, Ulrike" uniqKey="Schueler U" first="Ulrike" last="Schueler">Ulrike Schueler</name>
</region>
<name sortKey="Blanchette Mackie, Joan" sort="Blanchette Mackie, Joan" uniqKey="Blanchette Mackie J" first="Joan" last="Blanchette-Mackie">Joan Blanchette-Mackie</name>
<name sortKey="Brady, Roscoe" sort="Brady, Roscoe" uniqKey="Brady R" first="Roscoe" last="Brady">Roscoe Brady</name>
<name sortKey="Demosky, Stephen" sort="Demosky, Stephen" uniqKey="Demosky S" first="Stephen" last="Demosky">Stephen Demosky</name>
<name sortKey="Dwyer, Nancy" sort="Dwyer, Nancy" uniqKey="Dwyer N" first="Nancy" last="Dwyer">Nancy Dwyer</name>
<name sortKey="Hanover, John" sort="Hanover, John" uniqKey="Hanover J" first="John" last="Hanover">John Hanover</name>
<name sortKey="Kaneski, Christine" sort="Kaneski, Christine" uniqKey="Kaneski C" first="Christine" last="Kaneski">Christine Kaneski</name>
<name sortKey="Remaley, Alan" sort="Remaley, Alan" uniqKey="Remaley A" first="Alan" last="Remaley">Alan Remaley</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002236 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002236 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= PMC:5059196 |texte= A Short Synthetic Peptide Mimetic of Apolipoprotein A1 Mediates Cholesterol and Globotriaosylceramide Efflux from Fabry Fibroblasts }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26683465" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |